There Is Clear Momentum For BioNexus Gene Lab Corp (NASDAQ: BGLC)

BioNexus Gene Lab Corp (BGLC) concluded trading on Thursday at a closing price of $6.63, with 6.65 million shares of worth about $44.11 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 91.62% during that period and on July 17, 2025 the price saw a gain of about 56.00%. Currently the company’s common shares owned by public are about 1.80M shares, out of which, 1.17M shares are available for trading.

Stock saw a price change of 9.77% in past 5 days and over the past one month there was a price change of 123.61%. Year-to-date (YTD), BGLC shares are showing a performance of 25.00% which increased to 137.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.01 but also hit the highest price of $15.60 during that period. The average intraday trading volume for BioNexus Gene Lab Corp shares is 989.90K. The stock is currently trading 40.11% above its 20-day simple moving average (SMA20), while that difference is up 77.34% for SMA50 and it goes to 94.38% higher than SMA200.

BioNexus Gene Lab Corp (NASDAQ: BGLC) currently have 1.80M outstanding shares and institutions hold larger chunk of about 0.88% of that.

The stock has a current market capitalization of $11.91M and its 3Y-monthly beta is at 1.80. It has posted earnings per share of -$1.18 in the same period. It has Quick Ratio of 3.44 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BGLC, volatility over the week remained 26.38% while standing at 19.91% over the month.

Analysts are in expectations that BioNexus Gene Lab Corp (BGLC) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.